tadalafil has been researched along with HbS Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chalam, KV; Grover, S; Murthy, RK; Perez, L; Priluck, JC | 1 |
| Bivalacqua, TJ; Burnett, AL; Champion, HC; Musicki, B | 1 |
2 other study(ies) available for tadalafil and HbS Disease
| Article | Year |
|---|---|
Acute, bilateral, concurrent central retinal artery occlusion in sickle cell disease after use of tadalafil (Cialis).
Topics: Acute Disease; Adult; Anemia, Sickle Cell; Carbolines; Familial Primary Pulmonary Hypertension; Female; Fluorescein Angiography; Humans; Hypertension, Pulmonary; Papilledema; Phosphodiesterase 5 Inhibitors; Retinal Artery Occlusion; Tadalafil; Tomography, Optical Coherence | 2013 |
Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adult; Anemia, Sickle Cell; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Male; Nitric Oxide; Penile Erection; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Priapism; Purines; Recurrence; Signal Transduction; Sildenafil Citrate; Sulfones; Tadalafil | 2006 |